Drug firm Vivimed Labs Ltd on Wednesday announced the sale of its specialty chemicals division to Clariant Chemicals India, a subsidiary of Clariant AG Switzerland, at an enterprise value of $58 million (Rs 380 crore).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
